Brain Metastases

Oncology·MeSH: Brain Neoplasms

5 drugs in development·5 companies·8 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
tukysa	Seagen Inc. (SGEN)

Phase 3(1)

Drug	Company
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)

Phase 2(2)

Drug	Company
rad101	Radiopharm Theranostics Limited (RADX)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

Phase 4(1)

Drug	Company
Memantine	SUPERNUS PHARMACEUTICALS, INC. (SUPN)

BioSniper tracks 5 drugs in development for Brain Metastases across 5 companies.

There are 8 clinical trials targeting Brain Metastases tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.